Atlas Trials

Efficacy and Safety of Stellate Ganglion Block With Lidocaine Combined Platelet-rich Plasma to Treat Chronic Migraine

Clinical trial NCT06653218 · COMPLETED

Trial details

NCT number
NCT06653218
Sponsor
Beijing Tiantan Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Platelet-rich PlasmaChronic Migraine
Start date
2024-10-20
Primary completion
2025-06-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.